Restricted disease propagation in multiple system atrophy with prolonged survival

Neuropathol Appl Neurobiol. 2015 Aug;41(5):681-5. doi: 10.1111/nan.12195. Epub 2015 May 2.

Authors

Heather McCann¹, Andrew B McGeachie^{1

2}, Paul Silberstein³, Simon J G Lewis⁴, Glenda M Halliday^{1

2}

Affiliations

¹ Neuroscience Research Australia, Sydney, New South Wales, Australia.
² Medicine, University of New South Wales, Sydney, New South Wales, Australia.
³ Neurology, Royal North Shore and North Shore Private Hospitals, Sydney, New South Wales, Australia.
⁴ Brain & Mind Research Institute, University of Sydney, Sydney, New South Wales, Australia.

PMID: 25388985
DOI: 10.1111/nan.12195

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged, 80 and over
Brain / pathology
Disease Progression*
Fatal Outcome
Female
Humans
Levodopa / therapeutic use
Multiple System Atrophy / complications
Multiple System Atrophy / drug therapy
Multiple System Atrophy / pathology*

Substances

Levodopa